Home/ Supplements/ Nac/ N-Acetyl Cysteine 600 mg

N-Acetyl Cysteine 600 mg

product on market Capsule Swanson Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for N-Acetyl Cysteine 600 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Veggie Capsule(s)
Serving Size
60
Servings
Non-Nutrient/Non-Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

AjiPure Pharmaceutical Grade N-Acetyl-L-Cysteine
600 mg

Other Ingredients

Rice Flour Hypromellose Magnesium Stearate
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use: As a dietary supplement, take one veggie capsule per day with water or as recommended by your healthcare provider.

Warnings & Precautions

Warning: For adults only.

Do not take this product if you are pregnant or nursing.

Consult your healthcare provider before use if you are taking any prescription medication or if you have a medical condition.

Discontinue use if you experience gastrointestinal discomfort.

Keep out of reach of children.

Do not use if seal is broken.

Formulation Notes

Potent antioxidant that supports brain and liver health Supports detoxification of environmental toxins and pollutants

Antioxidant support

N-Acetyl Cysteine 600 mg per capsule

Featuring AjiPure

Additional Information

Science-backed quality since 1969

Store in a cool, dry place.

Metadata

Product Details

UPC / SKU0 87614 02458 5
DSLD Entry Date2024-03-22
Product TypeNon-Nutrient/Non-Botanical
FormCapsule
BrandSwanson
DSLD ID308676
Data Updated2026-04-11
Research

Research Evidence

41
Research Sources
51
Avg Quality
19
Rct
13
Meta Analysis
9
Clinical Trial
B N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication
Meta Analysis The Cochrane database of systematic reviews 2019 PubMed DOI
B Effect of high-dose N-acetylcysteine on exacerbations and lung function in patients with mild-to-moderate COPD: a double-blind, parallel group, multicentre randomised clinical trial
Rct Nature communications 2024 PubMed DOI
B N-acetylcysteine for non-paracetamol (acetaminophen)-related acute liver failure
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis
Meta Analysis European respiratory review : an official journal of the European Respiratory Society 2015 PubMed DOI
B A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
Rct BMC medicine 2019 PubMed DOI
B Efficacy of N-acetylcysteine for patients with depression: An updated systematic review and meta-analysis
Meta Analysis General hospital psychiatry 2024 PubMed DOI
B Cysteine, cystine or N-acetylcysteine supplementation in parenterally fed neonates
Meta Analysis The Cochrane database of systematic reviews 2006 PubMed
B N-acetylcysteine as an adjunctive treatment for bipolar depression: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Bipolar disorders 2021 PubMed DOI
B N-acetylcysteine as an adjunctive treatment for bipolar depression and major depressive disorder: a systematic review and meta-analysis of double-blind, randomized placebo-controlled trials
Meta Analysis Psychopharmacology 2020 PubMed DOI
B N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses
Meta Analysis Archivos de bronconeumologia 2024 PubMed DOI
View all evidence for Nac →
Compare

Similar Products

View all Nac products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.